期刊文献+

氯吡格雷联合阿司匹林治疗不稳定型心绞痛的疗效观察 被引量:10

Clinical study on the treatment of unstable angina with clopidogrel and aspirin
下载PDF
导出
摘要 目的:观察氯吡格雷联合阿司匹林治疗不稳定型心绞痛的临床效果。方法:选择2006年1月至2012年3月郏县人民医院心内科诊治的400例不稳定型心绞痛患者为研究对象。对照组(200例)给予阿司匹林,实验组(200例)给予氯吡格雷和阿司匹林,观察两组治疗6个月的效果及心血管事件的发生率。结果:治疗6个月后,实验组心绞痛较对照组明显缓解,心血管事件发生率显著降低,两组差异有统计学(P<0.05)。结论:氯吡格雷联合阿司匹林治疗不稳定型心绞痛可显著提高临床疗效,降低心血管事件的发生率。 Objective: To observe the effects of treatment and incidence of adverse cardiac events of unstable angina with clopidogrel and aspirin during 6 months. Methods : 400 patients diagnosed as unstable angina in The First Pepeole Hospital of Jiaxian from January 2006 to March 2012 were selected as the research object. These patients were randomly divided into observation group( treated with clopidogrel and aspirin) and control group (treated with aspirin). The clinical outcome and the incidence of cardiac events of two groups were compared after 6 months. Results: Compared with control group, the clinical outcome of observation group was significantly better and the incidence of cardiac was lower. Conclusion : The combined use of clopidogrel and aspirin for unstable angina patients could significantly improve clinical outcome and prevent adverse cardiac events.
出处 《河南医学研究》 CAS 2014年第4期22-23,共2页 Henan Medical Research
关键词 氯吡格雷 不稳定型心绞痛 阿司匹林 疗效 clopidogrel unstable angina aspirin therapeutic effect
  • 相关文献

参考文献5

二级参考文献12

  • 1[1]PatriciaAG, Kandice KM, Emilio DP, et al. Profile and prevalence of aspirin resistance in patients with cardiovascular disease[J]. Am J Cardiol, 2001, 88:230 - 235
  • 2[2]Mehta SR. Aspirin and clopidogrel in patients with ACS undergoing PCI: CURE and PCI- CURE[J] .J Invasive Cardiol, 2003,15(Suppl B): 17B - 20B
  • 3[3]Simoons ML. Effect of glycoprotein Ⅱ b/Ⅲ a receptor blocker abciximab on outcome in patients with acute coronary syndromes without early coronary revascularisation: the GUSTO IV- ACS randomised trial[J].Lancet, 2001, 357(9272): 1915 - 1924
  • 4[4]De Lemos JA, Antman EM, Gibson CM, et al. Abciximab improves both epicardial flow and myocardial reperfusion in ST- elevation myocardial infarction.Observations from the TIMI 14 trial[J]. Circulation,2000, 101(3) :239 - 243
  • 5[5]Topol EJ. Reperfusion therapy for acute myocardial infarction with fibrinolytic therapy or combination reduced fibrinolytic therapy and platelet glycoprotein Ⅱ b/Ⅲa inhibition: the GUSTO V randomised trial[J]. Lancet, 2001, 357(9272) :1905 - 1914
  • 6[6]Wallentin L, Goldstein P, Armstrong PW, et al. Efficacy and safety of tenecteplase in combination with the low - molecular- weight heparin enoxaparin or unfractionated heparin in the prehospital setting: the Assessment of the Safety and Efficacy of a New Thrombolytic Regimen (ASSENT) - 3 PLUS randomized trial in acute myocardial infarction [J ]. Circulation, 2003, 108(2): 135 - 142
  • 7[7]Antman EM, Louwerenburg HW, Baars HF, et al. Enoxaparin as adjunctive antithrombin therapy for STelevation myocardial infarction: results of the ENTIRE-Thrombolysis in Myocardial Infarction (TIMI) 23Trial[J]. Circulation, 2002, 105(14): 1642 - 1649
  • 8[8]Simoons M, Krzeminska - Pakula M, Alonso A, et al.Improved reperfusion and clinical outcome with enoxaparin as an adjunct to streptokinase thrombolysis in acute myocardial infarction. The AMI- SK study[J].Eur Heart J, 2002, 23 (16) :1282 - 1290
  • 9岑均达.盐酸噻氯匹定的合成[J].中国医药工业杂志,1997,28(5):197-199. 被引量:13
  • 10李家增.应重视溶栓药物的血液学基础研究[J].中华医学杂志,2000,80(5):325-326. 被引量:5

共引文献2751

同被引文献44

引证文献10

二级引证文献56

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部